U.S. femtech startup CurieMD is offering menopause diagnosis and treatment prescription via a telehealth platform — beginning in California, where it launched late last year.

“The authors of the study released a press release prematurely that then became an overnight sensationalized story about hormone therapy causing breast cancer,” she explains.

And many OB-GYNs and primary care doctors really don’t have the time needed to explain the pros and cons of hormone therapy to their patients.

“I realized obviously I was only going to be able to see a very small number of patients and patients in my community.

“And then for menopausal patients they have the option of choosing bioidentical hormone therapy. | To read full story, visit https://startuparound.com/read/1581370208.0968657/CurieMD-is-using-telehealth-to-plug-the-menopause-support-gap-–-TechCrunch?ref=audio_experience